Portfolio company
HISHOH Biopharma㈱
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops next-generation allergen immunotherapies to treat patients suffering from allergic rhinitis, asthma, atopic dermatitis and food allergies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Histapharma
This company develops medicinal products for patients suffering from respiratory conditions and allergic diseases.
Desentum
This biopharmaceutical company develops allergen immunotherapy products to treat patients suffering from respiratory and food allergies.
Resistentia Pharmaceuticals AB
This company develops immunotherapeutic products for patients suffering from allergic asthma and inflammatory disorders.
ANERGIS SA
Anergis SA develops ultra-fast synthetic vaccines to treat patients suffering from frequent environmental allergies such as birch pollen and house dust mites.
Alladapt Immunotherapeutics
This biopharmaceutical company develops oral immunotherapies for patients with single or multiple food allergies to reduce the severity of allergic reactions.
Immune Regulation
The company develops biotherapeutic treatments to reset the immune system for patients with autoimmune and allergic diseases.
Stallergenes Greer
This biopharmaceutical company develops and manufactures allergen immunotherapy products for healthcare professionals treating patients with respiratory, food, and animal-related allergies.
Allergios
This company develops a cell-based diagnostic platform for clinicians to perform precise in vitro allergy tests using blood samples and automated visual analysis.
